Phase II clinical study of SH/TA-508, at ultrasound contrast agent: A dose-finding study of SH/TA-508 in color Doppler flow imaging in the kidney

1995 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []